glp-1 gip mechanism of action Two incretin hormones and GIP: Comparison their actions in insulin secretion and β cell preservation GLP-1 Agonists Can Be Heaven

NPJ Biofilms Microbiomes 10 (1), 2

The efficacy and safety of weekly semaglutide (2.4 mg) for the treatment of overweight and obesity was investigated in the Semaglutide Treatment Effect in People with Obesity (STEP) programme, which included individuals with overweight (BMI 27 kg/m 2 ) and complications, including dyslipidaemia, hypertension, sleep apnoea, cardiovascular disease and type 2 diabetes, or individuals with obesity (BMI 30 kg/m 2 ) with or without complications [26, 34,35,36,37,38,39]

2024;12(4) doi: 10.1080/21688370.2023.2292461

Footnotes Conflict of interest: No potential conflict of interest relevant to this article was reported

Gaucher, a rare disease affecting about one in every 50,000 people in the world population and up to one in 500 people in people of Ashkenazi (eastern and central European) Jewish heritage